Sanofi Vaccines - Prescribing Information | Sanofi USA
WEBAt Sanofi, find our vaccines, including influenza, meningitis, pertussis, and more. Get prescribing information and patient resources.
Sanofi Vaccines: Protecting Lives at Every Stage | Sanofi
WEBDiscover how vaccines save millions of lives annually, offering protection against many infectious diseases. Read about the range of Sanofi vaccines available.
Vaccines - Sanofi
WEBVaccines. From providing protection against disease at every stage of life to protecting humanity against emerging epidemics, vaccines help create and maintain healthy communities that keep life moving forward.
Sanofi Pasteur - Wikipedia
WEBSanofi Pasteur is the vaccines division of the French multinational pharmaceutical company Sanofi. Sanofi Pasteur is the largest company in the world devoted entirely to vaccines. It is one of four global producers of the yellow fever vaccine. [2]
Advancing Health: Sanofi's Vaccine Development & R&D | Sanofi
WEBSince Louis Pasteur first discovered the connection between micro-organisms and infection, generations of scientists have developed vaccines that train our immune systems to combat infectious diseases.
Sanofi flu vaccines licensed and approved for 2022-2023 …
WEBJul 1, 2022 · Sanofi flu vaccines licensed and approved for 2022-2023 influenza season, including CDC preferred higher-dose vaccines for adults 65+. * Fluzone ® High-Dose Quadrivalent (Influenza Vaccine) and Flublok ® Quadrivalent (Influenza Vaccine) are the only two flu vaccines proven to help prevent …
Newly licensed US manufacturing facility to increase ... - Sanofi
WEBSWIFTWATER, Pa., June 17, 2021 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research has granted approval to Sanofi Pasteur, the vaccines global business unit of Sanofi, for an additional influenza manufacturing facility located in Swiftwater, PA.
Flu Awareness: Understanding Influenza| Sanofi USA
WEBOct 1, 2023 · Flu vaccines can help reduce the risk of illness by 40-60% when they are well-matched against circulating flu viruses, according to the CDC. 8 There are different flu shot options for different age groups and high-risk populations. 1 Talk to your doctor about what your options are.
Sanofi announces positive Phase 1/2 study interim results for its …
WEBPARIS – September 28, 2021 – Positive interim results from a Phase 1/2 study 1 of Sanofi’s mRNA-based COVID-19 vaccine candidate confirm the potential of recently-acquired Translate Bio’s messenger RNA (mRNA) and lipid nanoparticle (LNP) platform and support Sanofi’s mRNA strategy.
FDA Approves Expanded Use of Adacel® (Tdap) Vaccine for ... - Sanofi
WEBJan 14, 2019 · It is now the first and only Tdap vaccine in the U.S. approved for a repeat dose in people 10 through 64 years of age 8 years or more after the first vaccination. Adacel is also the only Tdap vaccine available in a syringe made without natural rubber latex, which may help reduce risk to patients with an allergy. 2.
Skip to content